154 related articles for article (PubMed ID: 22994671)
1. Corticosteroid-induced hyperglycemia is increased 10-fold in patients with pemphigus.
Alavi A; Lowe J; Walsh S; Juurlink D; Mortaz-Hedjri S; Shear NH
Int J Dermatol; 2012 Oct; 51(10):1248-52. PubMed ID: 22994671
[TBL] [Abstract][Full Text] [Related]
2. Treatment of pemphigus and pemphigoids.
López-Jornet P; Bermejo-Fenoll A
Med Oral Patol Oral Cir Bucal; 2005; 10(5):410-1. PubMed ID: 16264376
[No Abstract] [Full Text] [Related]
3. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
[TBL] [Abstract][Full Text] [Related]
4. Pemphigus and pemphigoid.
Matsuoka LY
Am Fam Physician; 1981 Aug; 24(2):113-5. PubMed ID: 7020393
[TBL] [Abstract][Full Text] [Related]
5. [Dexamethasone-cyclophosphamide pulse therapy in bullous autoimmune dermatoses].
Appelhans M; Bonsmann G; Orge C; Bröcker EB
Hautarzt; 1993 Mar; 44(3):143-7. PubMed ID: 8463094
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.
Gürcan HM; Ahmed AR
Am J Clin Dermatol; 2009; 10(6):383-96. PubMed ID: 19824739
[TBL] [Abstract][Full Text] [Related]
7. Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid.
Budimir J; Mihić LL; Situm M; Bulat V; Persić S; Tomljanović-Veselski M
Acta Clin Croat; 2008 Mar; 47(1):13-8. PubMed ID: 18714642
[TBL] [Abstract][Full Text] [Related]
8. [Aspects of corticoid therapy in patients with pemphigus and pemphigoid in the oral cavity].
Slivka T
Sb Lek; 1990 Sep; 92(8-9):258-61. PubMed ID: 2237246
[No Abstract] [Full Text] [Related]
9. Analysis of current therapy and clinical outcome in childhood pemphigus vulgaris.
Mabrouk D; Ahmed AR
Pediatr Dermatol; 2011; 28(5):485-93. PubMed ID: 21883426
[TBL] [Abstract][Full Text] [Related]
10. Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid.
Gürcan HM; Ahmed AR
Br J Dermatol; 2009 Oct; 161(4):723-31. PubMed ID: 19548961
[TBL] [Abstract][Full Text] [Related]
11. A case of concurrent pemphigoid vegetans and pemphigus vegetans resolving without oral corticosteroid.
Hatano Y; Ishikawa K; Koga H; Ishii N; Hashimoto T; Takeo N; Shimada H; Sakai T; Okamoto O; Fujiwara S
Br J Dermatol; 2014 May; 170(5):1192-4. PubMed ID: 24359309
[No Abstract] [Full Text] [Related]
12. Autoimmune blistering diseases in the elderly.
Parker SR; MacKelfresh J
Clin Dermatol; 2011; 29(1):69-79. PubMed ID: 21146735
[TBL] [Abstract][Full Text] [Related]
13. Targeting interleukin 4 receptor α: A new approach to the treatment of cutaneous autoimmune bullous diseases?
Russo R; Cozzani E; Gasparini G; Parodi A
Dermatol Ther; 2020 Jan; 33(1):e13190. PubMed ID: 31863534
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic experience in pemphigus and pemphigoid].
Aloi FG; Pippione M
G Ital Dermatol Venereol; 1984; 119(5):357-64. PubMed ID: 6392076
[No Abstract] [Full Text] [Related]
15. Frequency of IgA antibodies in pemphigus, bullous pemphigoid and mucous membrane pemphigoid.
Cozzani E; Drosera M; Parodi A; Carrozzo M; Gandolfo S; Rebora A
Acta Derm Venereol; 2004; 84(5):381-4. PubMed ID: 15370705
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the Prevalence and Risk Factors Associated With Glucocorticoid-Induced Diabetes Mellitus in Pemphigus Vulgaris Patients.
Darjani A; Nickhah N; Hedayati Emami MH; Alizadeh N; Rafiei R; Eftekhari H; Gharaei Nejad K
Acta Med Iran; 2017 Jun; 55(6):375-380. PubMed ID: 28843238
[TBL] [Abstract][Full Text] [Related]
17. [The hormonal profile of patients with pemphigus and bullous pemphigoid].
Klibson SK; Severovostokova VI; Shpanskaia LS
Vestn Dermatol Venerol; 1989; (7):37-41. PubMed ID: 2683471
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
Daoud YJ; Amin KG
Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
[TBL] [Abstract][Full Text] [Related]
19. The management of mucous membrane pemphigoid and pemphigus.
Knudson RM; Kalaaji AN; Bruce AJ
Dermatol Ther; 2010; 23(3):268-80. PubMed ID: 20597945
[TBL] [Abstract][Full Text] [Related]
20. Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting.
Recke A; Rose C; Schmidt E; Bröcker EB; Zillikens D; Sitaru C
J Am Acad Dermatol; 2009 Aug; 61(2):333-6. PubMed ID: 19615544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
